BioMed Research International

BioMed Research International / 2016 / Article
Special Issue

The Regulation of Innate Immunity by Nutritional Factors

View this Special Issue

Research Article | Open Access

Volume 2016 |Article ID 1069585 |

Gang Liu, Guiping Guan, Jun Fang, Yordan Martínez, Shuai Chen, Peng Bin, Veeramuthu Duraipandiyan, Ting Gong, Myrlene Carine B. Tossou, Naif Abdullah Al-Dhabi, Yulong Yin, "Macleaya cordata Extract Decreased Diarrhea Score and Enhanced Intestinal Barrier Function in Growing Piglets", BioMed Research International, vol. 2016, Article ID 1069585, 7 pages, 2016.

Macleaya cordata Extract Decreased Diarrhea Score and Enhanced Intestinal Barrier Function in Growing Piglets

Academic Editor: Kai Wang
Received24 May 2016
Accepted16 Jun 2016
Published25 Jul 2016


Macleaya cordata extract is of great scientific and practical interest to researchers, due to its antimicrobial and anti-inflammatory responses within experimental animals. This study was designed to determine the diarrhea score and innate immunity of growing piglets after they had received Macleaya cordata extract supplements. A total of 240 growing pigs were randomly assigned to one of three dietary treatments, with 8 replicates per treatment and 10 piglets per replicate. All pigs received a basal diet containing similar amounts of nutrients. The three treatments were a control (no additive), an antibiotic (200 mg/kg colistin), and the Macleaya cordata extract supplement group (40 mg/kg Macleaya cordata extract). The diarrhea score was calculated after D 28. The jejunal samples were obtained from five piglets selected randomly from each treatment on D 28. In comparison with the control group, the dietary Macleaya cordata extract and colistin group demonstrated a substantially decreased diarrhea score. The introduction of Macleaya cordata extract supplements to the diet significantly increased volumes of ZO-1 and claudin-1, particularly in comparison with the pigs in the control group (). The findings indicate that Macleaya cordata extract does enhance intestinal barrier function in growing piglets and that it could be used as a viable substitute for antibiotics.

1. Introduction

In recent years, there has been an increased focus on reducing or eliminating the use subtherapeutic antibiotics within livestock diets. For this reason, there has been a concerted effort to identify alternative effective therapies that could serve as a substitute for antibiotics in pig diets. The aim is to maintain acceptable performance levels and ensure food safety for consumers [1]. The medicinal plant extracts used as an alternative for antibiotics in swine diets are effective when it comes to increasing BW, intestinal health, nutrient digestibility, and antioxidative potential, and immunity. They also decrease the incidence and vulnerability to diarrhea [1, 2].

Macleaya cordata extract is believed to be an effective natural appetiser in swine, bovine, poultry, and even fish nutrition [3]. Macleaya cordata extract is blended from intact aerial parts and a fraction of quaternary benzo[c]phenanthridine alkaloids (QBAs), primarily sanguinarine (SG) and chelerythrine (CH), and standardised to 1.5% w/w SG [4].

Sanguinarine (SA), a quaternary benzo[c]phenanthridine alkaloid, is synthesised from dihydrosanguinarine, via the activities of dihydrobenzophenanthridine oxidase [5]. It has been shown to have beneficial effects. It is antimicrobial [6, 7], antifungal, adrenolytic, sympatholytic, immunomodulatory [5], and anti-inflammatory [8, 9].

Chelerythrine can be found within the greater celandine plant and a number of additional poppy Fumaria varieties. It is a quaternary benzo[c]phenanthridine alkaloid. According to studies, it mostly exhibits tumour resistant, microbe resistant, and inflammation resistant qualities. Plus, the substance is a powerful disruptor when it comes to PKC (or protein kinase C). As such, the prospective utilisation of CHE, as a form of inflammation resistance, has been the topic of much debate. Its qualities are linked to its capacity to engage with DNA and proteins [10]. This is an enzyme that plays an important part in the control of signal transduction, cell propagation, and cell variation [11].

For this study, we hypothesised that dietary supplementation with Macleaya cordata extracts might stimulate the immune system and, as a consequence, decrease the incidence of diarrhea in growing piglets. Thus, the objective of the study was to evaluate the impact of Macleaya cordata extract, as a dietary supplement, on diarrhea scores and the expression of tight junction proteins.

2. Materials and Methods

2.1. Experimental Design, Animals, and Housing

All of the procedures used in this study have been approved by the Institute of Subtropical Agriculture, the Chinese Academy of Sciences Animal Care and Use Committees. A total of 240 (Yorkshire × Landrace) × Duroc (56 d old; BW 15.82 ± 1.13 kg) pigs were obtained from a commercial swine herd in Guangdong, China. 240 piglets were assigned, in completely random design (but based on their BW), to 24 pens. The pens each contained a total of ten piglets. The process was carried out according to the experimental animal allotment program created by Kim et al. [12]. All pens were equipped with a feeder, a nipple-type drinker (with modification; more details later), and plastic-covered expanding metal floors. The room temperature was set at 28.0°C and slowly increased by 0.5°C/wk.

All piglets were fed the same basal diet, with a similar amount of nutrients (Table 1). This diet was formulated to meet or exceed the NRC (2012) nutrient specifications for pigs weighing 10 to 30 kg. In total, there were 3 experimental treatments and study groups: the negative control (NC; no in-feed or in-water additive), the antibiotic group (AB; in feed, 0.2 g/kg colistin), and the Macleaya cordata extract group (MC; in-feed, 40 mg/kg Macleaya cordata extract). The Macleaya cordata extract was kindly provided by Phytobiotics Futterzusatzstoffe GmbH, Eltville, in Germany and Micolta Bioresource Inc., in Changsha, China. The pigs had unlimited access to feed and water throughout the entirety of the study.

IngredientsContent (%)

Yellow corn74.90
Soybean meal21.0
L-Lysine HCL0.23
Poultry fat1.00
Vitamin premix11.00
Ground limestone1.00
Monocalcium phosphate0.70
Total composition
 DM, %89.70
 ME, Mcal/kg3.38
 CP, %19.40
 Ca, %0.68
 Total P, %0.49
 Available P, %0.21

The trace minerals in the premix provided (per kg diet): 5 mg Cu as CuSO4⋅5H2O; 80.5 mg Fe as FeSO4⋅7H2O; 0.15 mg I as KI; 0.3 mg Se as NaSeO3; 3.3 mg Mn as MnSO4⋅H2O; 81.3 mg Zn as ZnSO4⋅7H2O; 5 mg vitamin K (menadione); 2.1 mg vitamin B1; 15.2 mg vitamin B2; 30 μg vitamin B12; 5, 110 IU vitamin D3; 400 IU vitamin A; 18 IU vitamin E; and 80 mg choline chloride.
2.2. Sample Collection and Analytical Procedure

On days 7, 21, and 28 of treatment, 10 mL of blood was collected in plastic uncoated tubes between 8:00 and 10:00 a.m. After collection, these blood samples were centrifuged at 8000 ×g for 10 min at 4°C, with sera collected and frozen at −20°C until further analyses.

2.3. Faecal Score and Sampling

To evaluate diarrhea incidence, faecal consistency scores (0, normal; 1, soft faeces; 2, mild diarrhea; and 3, severe diarrhea) were determined for each pen. These scores were collected by a trained individual, but who had no prior knowledge of the dietary treatments provided. The incidence of diarrhea was calculated by dividing the total number of pigs with diarrhea by the total number of all experimental pigs. The rate ratios were then calculated. On day 28 of the experiment, a number of the pigs (1 pig/pen) were killed. 1 sample of jejunal mucosa was collected in a sterile sample bag and stored at −20°C until analysis.

2.4. Concentration of IgG, IgM, D-Lactate, DAO, and TNF-α

The serum volumes of IgM and IgG were calculated according to readings from the 1251 Radio Immunoassay Analysing tool (Beijing North Institute of Biological Technology, Beijing, China). A γ-calculating instrument GC-300 (Zhongjia Co., Ltd., Beijing) was also used as part of this equipment. Recommendations from the maker were followed at all times.

The volume of serum D-lactate and DAO were calculated using Beckman Cx4 Chemistry Analyser (Beckman Coulter, Brea, CA) with a kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, Jiangsu, China). Recommendations from the maker were followed at all times. All changes to or within the serum diamine oxidase were calculated with assay equipment.

The proportion of tumour necrosis factor-α (TNF-α) within serum was calculated via the use of a Porcine TNF-α Colorimetric ELISA tool (Nanjing Jiancheng Bioengineering Institute, Nanjing, Jiangsu, China). 50 μL of regular plus dilute solution (or 100 μL of the sample) was introduced to microplate wells. The wells had already been pretreated with capture antibody, as well as biotinylated antibody reagent. Identification relied on the utilisation of horseradish peroxidase, a stop solution of 0.18 N H2SO4, and TMB substrate. The identification parameter for TNF-α was 5 pg/mL. Merging was detected at 450 and 540 nm, with the use of the KC4 data evaluation programme and an ELISA plate tool.

2.5. Tight Junction Proteins Expression

The tight junction protein displays of occludin, claudin-1, and zonula occludens-1 (ZO-1) were calculated with the use of western blotting. Western blot testing was carried out via the use of a sophisticated chemiluminescence identification tool (Amersham, Illinois). The results were captured with the ChemiScope 3400 device (Clinx Science Instruments, Shanghai, China). They were evaluated with the use of Quantity One equipment (Bio-Rad, California, USA). The β-actin functioned as an interior control because it expressed no dissimilarities across the populations. The significance of the protein display was represented by the ratio of the densitometry units of β-actin and tight junction protein. For a short time, all protein was removed, according to the advice provided by a protein removal tool (KGP2100 from KeyGen Biotech, Nanjing, Jiangsu China). The mucosa proteins within the intestines were isolated with a polyacrylamide substance (Millipore, MA, USA). They were then introduced to polyvinylidene difluoride membranes. These membranes were kept secure and protected for twelve hours, at a temperature of 4°C, after the introduction of the first antibodies. After the introduction of the secondary antibody, they were kept at 25°C, for 120 minutes. The first antibodies (goat polyclonal claudin-1 antibody, β-actin rabbit antibody, and rabbit polyclonal ZO-1 antibody) were sourced from Santa Cruz Biotechnology (California, US). The secondary antibodies used were goat anti-rabbit IgG-HRP and rabbit anti-goat IgG-HRP (again, sourced from Santa Cruz Biotechnology).

2.6. Statistical Analysis

To evaluate and verify the results, an analysis of variance (or ANOVA) method was used for basic classification and order of a completely randomized design. Before ANOVA, the evenness of its variance was checked using the Bartlett technique. Then, the regularity of the information was tested using the Kolmogorov-Smirnov method. At certain points, a Duncan multiple range method (in accordance with SPSS 22.00 Statistical Software) was utilised to calculate dissimilarities across mean values.

3. Results

Figure 1 demonstrates that the diarrhea score for pigs in the MC group was lower than that of the NC group and the AB group. The score for the AB group was still lower than that of the NC group.

Table 2 demonstrates the impact of dietary supplementation with Macleaya cordata extract on the serum biochemical parameters and volume of antibodies in the growing pigs on days 7, 14, and 28 after the start of the study.

ParameterDietary supplementationSEM±P value
No additiveMacleaya cordata extractColistin

D 7 after initiation of treatment
D-Lactate, mg/L7.959.127.061.1190.477
DAO, units/mL2.532.462.420.2160.536
IgG, mg/mL138.41174.45143.4410.801<0.05
IgM, mg/mL43.2039.6038.406.6350.869
TNF-α, pg/mL62.3458.9859.367.5100.478
D 14 after initiation of treatment
D-Lactate, mg/L10.268.217.450.813<0.05
IgG, mg/mL183.89176.17184.5820.040.947
IgM, mg/mL50.0049.4051.007.7990.989
TNF- α64.1359.4261.376.5900.589
D 28 after initiation of treatment
D-Lactate, mg/L9.109.367.601.1690.535
IgG, mg/mL196.38219.60201.7216.7680.604
IgM, mg/mL63.2049.6070.006.224<0.05

Means within the same row with different superscript differ significantly ().
The experiment lasted 28 d; .

On day 7, the concentration of IgG was higher (P < 0.05) in pigs from the MC group, when compared with the other 2 groups. The serum concentrations of D-lactate, DAO, IgM, and TNF-α did not exhibit any substantial or notable differences (P > 0.05) across the treatments, on day 7 after the launch of the study.

On day 14, the serum concentration of D-lactate was the only parameter that showed a significant difference ( < 0.05) across the treatments. There was a lower concentration in pigs from the AB group. The other serum parameters for the pigs remained the same ( > 0.05), due to the impact of dietary supplementation with Macleaya cordata extract (Table 2). On day 28, the serum concentration of IgM decreased in the pigs from the MC group, in comparison with those from the AB group ( < 0.05). The other parameters exhibited no notable changes (P < 0.05), as a consequence of the experimental treatments.

Figure 2 demonstrates the protein expression levels of occludin, ZO-1, and claudin-1 within the jejunal mucosa. The occludin levels did not notably differ across any of the groups. The protein expression levels of ZO-1 within the jejunal mucosa increased substantially (P < 0.05), in comparison with those in the NC and AB groups. Also, ZO-1 protein increased significantly (P < 0.05), in comparison with that of the NC group. Thus, the dietary supplementation of Macleaya cordata extract and antibiotics substantially increased the expression of Claudin-1 (P < 0.05), particularly when compared with that of the NC group.

4. Discussion

Diarrheal syndrome occurs primarily because of an increase in Escherichia coli and others pathogenic bacteria inside the gut after weaning. This leads to a loss of water and electrolytes, via the semiliquid faeces [1]. According to Kommera et al. [13] and Kong et al. [1], the supplementation of medicinal plant extracts decreases diarrhea incidence in pigs, mainly because the extract has antimicrobial properties and it aids in the regulation of organic functions, intestinal pH, and peristalsis.

As Newton et al. [7] explain, the antimicrobial properties of sanguinarine have been clearly demonstrated. If it is added to swine diets, as a supplement, it has the potential to support the intestinal colonisation of beneficial bacteria and increase competitive exclusion in GIT. It also reduces water secretion from the intestinal epithelial cells and/or improves the absorption of water and nutrients from the intestinal lumen [1]. These results are primarily caused by an increase in the metabolism of biomolecules and by antioxidant activities within the small-intestinal mucosa.

There is a relationship between intestinal pH, microflora population, and diarrhea incidence in pigs [1]. This is clear because both stabilization of the intestinal pH value at a reasonably low level and the maintenance of an optimal balance of intestinal microbiota play a major role in the reduction of diarrhea incidence [5, 14]. It is noteworthy then that although these key results relating to the the antidiarrheal effect of medicinal plant extracts have been seen in piglets, we also found a similar response in growing pigs.

Crucially, Macleaya cordata extract also has other important characteristics, such as its anti-inflammatory effect and immunomodulatory properties [5, 8, 9], which improve intestinal immune function. This reduces inflammation within the small-intestinal mucosa that usually develops as a result of stress. Although the precise mechanisms are not clear, our results demonstrate that Macleaya cordata extract, provided as a natural supplement to growing pigs, could be a viable substitute for feed antibiotics.

Serum antibody volume is another useful indicator of humoral immunity. Actually, IgG and IgM are key components and signifiers of humoral immunity in all mammals because they are the major serum immunoglobulins. They protect the extravascular compartment against pathogenic bacteria and microorganisms [15]. Furthermore, IgG also has antibacterial and antitoxin effects [16]. These findings suggest that a higher concentration (P < 0.05) of IgG in pigs of MC group (Table 2) leads to an increase in the production of antibodies by B lymphocytes. This is beneficial for immune status and, consequently, animal response [15, 17].

It should be noted that this serum antibody (IgG) did not increase (P < 0.05 = on subsequent days (d 14 and 28)), perhaps because of a higher immunological stability in the pigs. However, other studies on medicinal plant additives have shown a variability in the serum concentration of IgG in pigs [15, 17]. Interestingly, the serum concentration of IgM did decrease (P < 0.05 = in pigs from MC group). IgM is the first to be synthesised, as a response to infection [17]. Despite variations in the serum concentration of immunoglobulins, after supplementation with Macleaya cordata extract, we observed a healthy response in growing pigs (Table 2). According to the work of Tewari et al. [18], the underlying mechanisms that regulate immunological function are likely to be multifactorial. As such, they recommended that future studies use molecular biology and proteomics technologies.

When it comes to sustaining and protecting the translocation of bacteria in the intestines, an undamaged intestinal barrier is very important. It stops allergenic and toxic substances from making their way inside the gut and becoming a danger [19, 20]. D-Lactate and diamine oxidase can usually be found in modest amounts, within the circulation [21]. Yet, if the protective capacity of the intestine is decreased, mucosal permeability begins to rise. This enables a larger volume of D-lactate and DAO to get inside the peripheral circulation. For this reason, D-lactic acid and plasma DAO can potentially be used as indicators of damage to the intestinal barrier system [22, 23]. This paper has discussed, in depth, the relationship between MC extracts and this degree of protection within the intestine. For example, there is much evidence to support the idea that if baby pigs are taken from their mothers and weaned too early, it leads to diminished intestinal barrier capacities [24, 25]. On the other hand, according to the data collected, MC extract supplements actually boost jejunal mucosa DAO. However, it lowers the volume of plasma DAO and D-lactate. This suggests that intestinal mucosal development and barrier strength can be enhanced by introducing MC supplements.

The intestinal barrier is tightly controlled by a carefully arranged piece of the epithelial junctional complex. It is usually called “the tight junction” [26]. The porousness and protective capacities of the intestine have, for a long time, been treated as signifiers of intestinal epithelial barrier strength. It consists of various distinct proteins, like the transmembrane protein occludin [27], some members of the claudin family [28], junctional adhesion molecule [29], various linker proteins such as ZO-1, and more. The most valuable and essential are occludin, ZO-1, and claudin-1 because they are linked to the functional and operational management of the tight junctions [30]. ZO-1 is a valuable linker protein for the tight junction because it joins the C-terminal selections of β-actin and occludin [30]. It also functions as a connection between cytoskeleton proteins and the plasma membrane. Claudin-1 seems to be mostly linked to the display of ZO-1 inside the small intestine. Finally, for the epithelial tight junction, occludin is a vital membrane protein. It plays a big part when it comes to sustaining the strength and barrier quality of the tight junction [27]. For this study, we calculated fluctuations within the display of occludin, ZO-1, and claudin-1 at the mRNA level. This allowed us to more accurately judge the molecular catalyst for the decrease in intestinal strength within growing pigs after they had been given artificially increased levels of Zn. The outcomes show that adding Macleaya cordata to the diet, as an additional supplement, boosts volumes of ZO-1 and Claudin-1 proteins.

The experiment shows that introducing Macleaya cordata extracts to the diet, as an additional supplement, can increase resistance to intestinal damage, to some degree. This is achieved, throughout the growing stage, via increases in the volume and generation of claudin-1 and ZO-1. A number of earlier studies, on animals, had already made it clear that intestinal strength is closely linked to claudin-1 and ZO-1 volumes [31]. According to Kansagra et al. [32], fluctuations within intestinal strength, throughout the weaning stage, can be explained by the deterioration of tight junction reliability and quality. These studies discussed the fact that baby pigs in the weaning phase suffer various pressures (e.g., swapping from a liquid diet to a solid one). This makes them vulnerable to infections created by enterotoxigenic E. coli [33]. It happens because tight junction proteins have become disarrayed or their volumes have been lowered [21]. For all of these reasons, epithelial strength is compromised. In turn, this unusually high degree of intestinal porousness leads to increased antigenic vulnerability, a weaker immune system, and persistent inflammation. This greatly decreases barrier strength [34] and, eventually, leads to dangerous levels of after-weaning sickness.

To summarise, boosting the diet with Macleaya cordata extract supplements caused a reduction in faecal dysfunction. This result was underscored by larger volumes of claudin-1 and ZO-1. Consequently, the fortifying impact of Macleaya cordata supplements may be, to some degree, linked with the enhancement of intestinal barrier strength, particularly when it comes to treating conditions like diarrhea.

Competing Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Authors’ Contributions

Gang Liu and Guiping Guan contributed equally to this paper.


This study was in part supported by the National Natural Science Foundation of China (nos. 31330075 and 31110103909), National Key Research and Development Program of China (2016YFD0500504), National Basic Research Program of China (2013CB127302, 2013CB127301), the Science and Technology Department of Hunan province (13JJ2034, 2013FJ3011, 2014NK3048, 2014NK4134, and 2014WK2032), and the Ministry of Agriculture 948 Program (2016-X47, 2015-Z64). This project was also partially financially supported by King Saud University, through Vice Deanship of Research Chairs.


  1. X. F. Kong, G. Y. Wu, Y. P. Liao et al., “Effects of Chinese herbal ultra-fine powder as a dietary additive on growth performance, serum metabolites and intestinal health in early-weaned piglets,” Livestock Science, vol. 108, no. 1–3, pp. 272–275, 2007. View at: Publisher Site | Google Scholar
  2. W. Windisch, K. Schedle, C. Plitzner, and A. Kroismayr, “Use of phytogenic products as feed additives for swine and poultry,” Journal of Animal Science, vol. 86, no. 14, pp. E140–E148, 2008. View at: Google Scholar
  3. S. L. Vieira, O. A. Oyarzabal, D. M. Freitas et al., “Performance of broilers fed diets supplemented with sanguinarine-like alkaloids and organic acids,” The Journal of Applied Poultry Research, vol. 17, no. 1, pp. 128–133, 2008. View at: Publisher Site | Google Scholar
  4. Z. Dvořák, I. Sovadinová, L. Bláha, J. P. Giesy, and J. Ulrichová, “Quaternary benzo[c]phenathridine alkaloids sanguinarine and chelerythrine do not affect transcriptional activity of aryl hydrocarbon receptor: analyses in rat hepatoma cell line H4IIE.luc,” Food and Chemical Toxicology, vol. 44, no. 9, pp. 1466–1473, 2006. View at: Publisher Site | Google Scholar
  5. M. M. Chaturvedi, A. Kumar, B. G. Darnay, G. B. N. Chainy, S. Agarwal, and B. B. Aggarwal, “Sanguinarine (Pseudochelerythrine) is a potent inhibitor of NF-κB activation, IκBα phosphorylation, and degradation,” Journal of Biological Chemistry, vol. 272, no. 48, pp. 30129–30134, 1997. View at: Publisher Site | Google Scholar
  6. C. Walker, “Effects of sanguinarine and Sanguinaria extract on the microbiota associated with the oral cavity,” Journal (Canadian Dental Association), vol. 56, no. 7, pp. 13–30, 1990. View at: Google Scholar
  7. S. M. Newton, C. Lau, S. S. Gurcha, G. S. Besra, and C. W. Wright, “The evaluation of forty-three plant species for in vitro antimycobacterial activities; isolation of active constituents from Psoralea corylifolia and Sanguinaria canadensis,” Journal of Ethnopharmacology, vol. 79, no. 1, pp. 57–67, 2002. View at: Publisher Site | Google Scholar
  8. J. Lenfeld, M. Kroutil, E. Marsálek, J. Slavík, V. Preininger, and V. Simánek, “Antiinflammatory activity of quaternary benzophenanthridine alkaloids from Chelidonium majus,” Planta Medica, vol. 43, no. 2, pp. 161–165, 1981. View at: Publisher Site | Google Scholar
  9. C. K. Yiu and S. H. Wei, “Clinical efficacy of dentifrices in the control of calculus, plaque, and gingivitis,” Quintessence International, vol. 24, no. 3, pp. 181–188, 1993. View at: Google Scholar
  10. D. Walterová, J. Ulrichová, I. Válka et al., “Benzo[c]phenanthridine alkaloids sanguinarine and chelerythrine: biological activities and dental care applications,” Acta Universitatis Palackianae Olomucensis Facultatis Medicae, vol. 139, pp. 7–16, 1995. View at: Google Scholar
  11. J. Malíková, A. Zdařilová, A. Hlobilková, and J. Ulrichová, “The effect of chelerythrine on cell growth, apoptosis, and cell cycle in human normal and cancer cells in comparison with sanguinarine,” Cell Biology and Toxicology, vol. 22, no. 6, pp. 439–453, 2006. View at: Publisher Site | Google Scholar
  12. B. G. Kim, M. D. Lindemann, G. L. Cromwell, A. Balfagon, and J. H. Agudelo, “The correlation between passage rate of digesta and dry matter digestibility in various stages of swine,” Livestock Science, vol. 109, no. 1–3, pp. 81–84, 2007. View at: Publisher Site | Google Scholar
  13. S. K. Kommera, R. D. Mateo, F. J. Neher, and S. W. Kim, “Phytobiotics and organic acids as potential alternatives to the use of antibiotics in nursery pig diets,” Asian-Australasian Journal of Animal Sciences, vol. 19, no. 12, pp. 1784–1789, 2006. View at: Publisher Site | Google Scholar
  14. Z.-R. Tang, Y.-L. Yin, C. M. Nyachoti et al., “Effect of dietary supplementation of chitosan and galacto-mannan- oligosaccharide on serum parameters and the insulin-like growth factor-I mRNA expression in early-weaned piglets,” Domestic Animal Endocrinology, vol. 28, no. 4, pp. 430–441, 2005. View at: Publisher Site | Google Scholar
  15. X. F. Kong, G. Y. Wu, Y. P. Liao et al., “Dietary supplementation with Chinese herbal ultrafine powder enhances cellular and humoral immunity in earlyweaned piglets,” Livestock Science, vol. 108, no. 1–3, pp. 94–98, 2007. View at: Publisher Site | Google Scholar
  16. L. L. Li, X. Wu, H. Z. Peng et al., “The effect of dietary addition of a polysaccharide from Atractylodes macrophala Koidz on growth performance, immunoglobulin concentration and IL-1β expression in weaned piglets,” The Journal of Agricultural Science, vol. 147, no. 5, pp. 625–631, 2009. View at: Publisher Site | Google Scholar
  17. J. Gong, F. Yin, Y. Hou, and Y. Yin, “Review: chinese herbs as alternatives to antibiotics in feed for swine and poultry production: potential and challenges in application,” Canadian Journal of Animal Science, vol. 94, no. 2, pp. 223–241, 2014. View at: Publisher Site | Google Scholar
  18. A. K. Tewari, S. Mohanty, and S. Roy, “Proteomics and nutrition research,” in Genomics, Proteomics and Metabolomics in Nutraceuticals and Functional Foods, pp. 243–252, John Wiley & Sons, Chichester, UK, 2015. View at: Google Scholar
  19. L. Montagne, G. Boundry, C. Favier, I. Le Huërou-Luron, J.-P. Lallès, and B. Sève, “Main intestinal markers associated with the changes in gut architecture and function in piglets after weaning,” British Journal of Nutrition, vol. 97, no. 1, pp. 45–57, 2007. View at: Publisher Site | Google Scholar
  20. P. J. A. Wijtten, J. V. D. Meulen, and M. W. A. Verstegen, “Intestinal barrier function and absorption in pigs after weaning: a review,” British Journal of Nutrition, vol. 105, no. 7, pp. 967–981, 2011. View at: Publisher Site | Google Scholar
  21. M. C. Wolvekamp and R. W. de Bruin, “Diamine oxidase: an overview of historical, biochemical and functional aspects,” Digestive Diseases, vol. 12, no. 1, pp. 2–14, 1994. View at: Google Scholar
  22. I. Fukudome, M. Kobayashi, K. Dabanaka et al., “Diamine oxidase as a marker of intestinal mucosal injury and the effect of soluble dietary fiber on gastrointestinal tract toxicity after intravenous 5-fluorouracil treatment in rats,” Medical Molecular Morphology, vol. 47, no. 2, pp. 100–107, 2014. View at: Publisher Site | Google Scholar
  23. C. Nielsen, J. S. Lindholt, E. J. Erlandsen, and F. V. Mortensen, “d-lactate as a marker of venous-induced intestinal ischemia: an experimental study in pigs,” International Journal of Surgery, vol. 9, no. 5, pp. 428–432, 2011. View at: Publisher Site | Google Scholar
  24. F. Smith, J. E. Clark, B. L. Overman et al., “Early weaning stress impairs development of mucosal barrier function in the porcine intestine,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 298, no. 3, pp. G352–G363, 2010. View at: Publisher Site | Google Scholar
  25. B. L. McLamb, A. J. Gibson, E. L. Overman, C. Stahl, and A. J. Moeser, “Early weaning stress in pigs impairs innate mucosal immune responses to enterotoxigenic E. coli challenge and exacerbates intestinal injury and clinical disease,” PLoS ONE, vol. 8, no. 4, Article ID e59838, 2013. View at: Publisher Site | Google Scholar
  26. T. Kucharzik, S. V. Walsh, J. Chen, C. A. Parkos, and A. Nusrat, “Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins,” The American Journal of Pathology, vol. 159, no. 6, pp. 2001–2009, 2001. View at: Publisher Site | Google Scholar
  27. V. Wong and B. M. Gumbiner, “A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier,” The Journal of Cell Biology, vol. 136, no. 2, pp. 399–409, 1997. View at: Publisher Site | Google Scholar
  28. K. Morita, M. Furuse, K. Fujimoto, and S. Tsukita, “Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 2, pp. 511–516, 1999. View at: Publisher Site | Google Scholar
  29. “Tight junction dynamics are regulated by the glycoprotein EpCAM : Epithelial Cell Adhesion Molecule (EpCAM) regulates claudin dynamics and tight junctions,” The Journal of Biological Chemistry, vol. 288, no. 17, pp. 12269–12269, 2013. View at: Publisher Site | Google Scholar
  30. A. S. Fanning, B. J. Jameson, L. A. Jesaitis, and J. M. Anderson, “The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton,” The Journal of Biological Chemistry, vol. 273, no. 45, pp. 29745–29753, 1998. View at: Publisher Site | Google Scholar
  31. K. Wang, X. Jin, Y. Chen et al., “Polyphenol-rich propolis extracts strengthen intestinal barrier function by activating AMPK and ERK signaling,” Nutrients, vol. 8, no. 5, p. 272, 2016. View at: Publisher Site | Google Scholar
  32. K. Kansagra, B. Stoll, C. Rognerud et al., “Total parenteral nutrition adversely affects gut barrier function in neonatal piglets,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 285, no. 6, pp. G1162–G1170, 2003. View at: Publisher Site | Google Scholar
  33. J. Osek, “Prevalence of virulence factors of Escherichia coli strains isolated from diarrheic and healthy piglets after weaning,” Veterinary Microbiology, vol. 68, no. 3-4, pp. 209–217, 1999. View at: Publisher Site | Google Scholar
  34. M. Bruewer, A. Luegering, T. Kucharzik et al., “Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms,” The Journal of Immunology, vol. 171, no. 11, pp. 6164–6172, 2003. View at: Publisher Site | Google Scholar

Copyright © 2016 Gang Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.